Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction

Clinical trial NCT05711719 · COMPLETED

Trial details

NCT number: NCT05711719
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metabolic Syndrome Coronary Microvascular Dysfunction

Start date: 2023-06-16
Primary completion: 2025-11-18
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.